Citation Tools
PDFEditorial
Phase I oncology trials: why the therapeutic misconception will not go away
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Phase I oncology trials: why the therapeutic misconception will not go away
Other content recommended for you
- Two concepts of therapeutic optimism
- Phase 1 oncology trials and informed consent
- Therapeutic appropriation: a new concept in the ethics of clinical research
- Donor-funded research: permissible, not perfect
- Are positive experiences of children in non-therapeutic research justifiable research benefits?
- Engaging African ancestry participants in SLE clinical trials
- Subjects’ views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study
- Vulnerability, therapeutic misconception and informed consent: is there a need for special treatment of pregnant women in fetus-regarding clinical trials?
- Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis
- Informed consent as an ethical requirement in clinical trials: an old, but still unresolved issue. An observational study to evaluate patient's informed consent comprehension